Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.

@article{Bien2012ImmunopathologyOA,
  title={Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.},
  author={Christian G. Bien and Angela Vincent and Michael Harry Barnett and Albert J. Becker and Ingmar Bl{\"u}mcke and Francesc Graus and Kurt A. Jellinger and David E. Reuss and Teresa Ribalta and J{\"u}rgen Schlegel and Ian J. Sutton and Hans Lassmann and Jan Bauer},
  journal={Brain : a journal of neurology},
  year={2012},
  volume={135 Pt 5},
  pages={
          1622-38
        }
}
Classical paraneoplastic encephalitis syndromes with 'onconeural' antibodies directed to intracellular antigens, and the recently described paraneoplastic or non-paraneoplastic encephalitides and antibodies against both neural surface antigens (voltage-gated potassium channel-complexes, N-methyl-d-aspartate receptors) and intracellular antigens (glutamic acid decarboxylase-65), constitute an increasingly recognized group of immune-mediated brain diseases. Evidence for specific immune mechanisms… Expand
Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies
TLDR
Treatments include first-line steroids, intravenous immunoglobulins, and plasma exchange, and second-line rituximab and cyclophosphamide, followed in many cases by steroid-sparing agents in the long-term. Expand
Immunoadsorption therapy in autoimmune encephalitides
TLDR
This study provides Class IV evidence that immunoadsorption combined with immunosuppression therapy is effective in patients with autoimmune encephalitis with surface antibodies and supports the pathogenic role of surface antibodies. Expand
Encephalitides with antibodies against intracellular antigens
*Corre Spitalg In recent years a large number of antibody-associated or antibody-defined encephalitides have been discovered. These conditions are often referred to as autoimmune encephalitides. TheExpand
Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system
TLDR
This work provides an overview of entities, clinical hallmarks, imaging features, characteristic laboratory, electrophysiological, cerebrospinal fluid and neuropathological findings, cellular and molecular disease mechanisms as well as therapeutic options in these two broad categories of inflammatory CNS disorders. Expand
Autoimmune Epilepsies
TLDR
Emerging findings in patients with immune-associated disorders of the gray central nervous system matter make it plausible that immunological therapies, preferably early after characterization of the antibodies, offer opportunities to restore the health of affected patients. Expand
Immune-mediated disorders.
TLDR
It is suggested that pathologic studies suggest an immune-mediated disease for Rasmussen encephalitis, CLIPPERS, acute cerebellitis, and Susac syndrome, and neuropathologic descriptions of HashimotoEncephalitis are rare and the pathogenesis deserves further study. Expand
The immunobiology of autoimmune encephalitides.
TLDR
The review stresses the importance of early detection, clinical recognition, proper antibody testing and early therapy initiation as these disorders, regardless of a known or not trigger, are potentially treatable responding to systemic immunotherapy with intravenous steroids, IVIg, rituximab or even bortezomid. Expand
Are Onconeural Antibodies a Clinical Phenomenology in Paraneoplastic Limbic Encephalitis?
TLDR
This review provides an overview on the pathogenesis and diagnosis of PNS, with emphasis on the role of antibodies in limbic encephalitis, and the current hypothesis of an autoimmune pathophysiology. Expand
Neuropathology of autoimmune encephalitides.
TLDR
This chapter focuses on the pathology and the pathogenetic mechanisms involved in these encephalitides and discusses some of the questions that are raised in this exciting new field. Expand
Treating a GAD65 Antibody-Associated Limbic Encephalitis with Basiliximab: A Case Study
TLDR
The correlation of the fCD8+TL in the CSF with clinical and paraclinical measures of disease activity combined with the unambiguous response to basiliximab strongly argues in favor of the putative pathogenic role f CD8+ TL in anti-GAD65 LE. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 53 REFERENCES
Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis
TLDR
The data point out to an induction of a cytotoxic, non-apoptotic, neuronal death in anti-Hu-associated PEM, and the increased ICAM-1 immunoreactivity may favor the infiltration of lymphocytes in the pathological areas. Expand
Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen
TLDR
GABA(B) receptor autoimmune encephalitis is a potentially treatable disorder characterised by seizures and, in some patients, associated with small-cell lung cancer and with other autoantibodies. Expand
Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma
TLDR
Findings coupled with recently reported in vitro data showing that antibodies downregulate the levels of NMDA receptors suggest that the antibody immune-response is more relevant than cytotoxic T-cell mechanisms in the pathogenesis of anti-NMDAR-associated encephalitis. Expand
Antibodies and neuronal autoimmune disorders of the CNS
We review the neuronal antibodies described in CNS disorders in order to clarify their diagnostic value, emphasize potentials pitfalls and limitations in the diagnosis of paraneoplastic neurologicalExpand
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series
TLDR
The term limbic encephalitis associated with antibodies against voltage-gated potassium channels should be changed to limbicEncephalitisassociated with LGI1 antibodies, and this disorder should be classed as an autoimmune synaptic encephalopathy. Expand
Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
TLDR
Once considered an extremely rare disorder, almost always related to cancer, and refractory to treatment, limbic encephalitis is now regarded as a relatively frequent disorder, often unrelated to cancer and with clinical-immunologic variants that respond to treatment. Expand
The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins
TLDR
There are a growing number of specific antibodies associated with new onset epilepsy, and these patients are likely to have an immune-mediated disorder that may benefit from immunotherapies. Expand
Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome
TLDR
Antibodies to mGluR5 should be considered in patients with symptoms of limbic encephalitis and HL (Ophelia syndrome) and recognition of this disorder is important because it can affect young individuals and is reversible. Expand
GABAB receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disorders
TLDR
GABABR-ab are the most common antibodies found in LE associated with SCLC previously considered “seronegative,” and in patients with GAD-ab, the frequency of GABABR-AB is low and only observed in the context of cancer. Expand
Autoimmune channelopathies
TLDR
The roles of antibodies to receptors and ion channels in the peripheral and central nervous systems are reviewed, concentrating on the recently defined autonomic and CNS conditions and on the role of antibody measurement in diagnosis and management. Expand
...
1
2
3
4
5
...